LONG
BEACH, Calif., June 25,
2024 /PRNewswire/ -- Food Allergy Institute (FAI) has
unveiled a pioneering study with the potential to transform the
lives of children suffering from cow's milk allergy. Published in
the Journal of Allergy and Clinical Immunology, the study
titled "Long Term Efficacy and Safety of Cow's Milk Anaphylaxis
Specific Immunotherapy: Allergen Unresponsiveness via the Tolerance
Induction Programâ„¢" demonstrates that children previously severely
allergic to cow's milk can now safely consume dairy products
without restrictions.
Food allergies affect approximately 8% of U.S. children,
equating to about 4.2 million young individuals, and milk allergy
is one of the hardest allergies to treat. In this first-of-its-kind
study, 214 pediatric patients underwent the Tolerance Induction
Programâ„¢ (TIP) for milk anaphylaxis.
FAI is the first health organization on record to use AI to
treat food allergies. The TIP program's innovative immunotherapy
leverages machine learning and artificial intelligence (AI) to
customize individual treatment plans and map out a safe and
efficient dosing strategy, allowing patients to achieve and
maintain clinical remission.
Key Findings:
- Largest Study: This is the largest study on
biosimilar protein immunotherapy for cow's milk anaphylaxis ever
published with 214 pediatric patients enrolled.
- Complete Remission: 100% of the participants
achieved milk allergy remission. All patients are now able to
openly consume unlimited amounts of milk.
- Safety Record: For the study, patients completed
56,443 food challenges, with only 6 (0.01%) incidents requiring
epinephrine.
- Sustained Results: All study participants have
maintained a year of remission without any incidents necessitating
epinephrine.
Dr. Inderpal Randhawa, the lead
researcher and corresponding author, expressed his excitement about
the study's results: "This groundbreaking study is a game changer
for children suffering from milk allergies. It demonstrates that
dairy allergies can achieve remission, enabling children who are
anaphylactic today to eventually consume milk without restriction.
As we continue to harness the power of AI in healthcare, this
pioneering approach represents a significant leap forward in
allergy treatment and personalized medicine, promising a future
where milk allergies no longer hinder daily life. This milestone
demonstrates the real-world success of AI in advancing medical
treatment, providing hope and improved quality of life for millions
of patients starting today."
The study highlights the effectiveness of the Tolerance
Induction Programâ„¢ (TIP) in treating cow's milk anaphylaxis. This
program, which has also shown effectiveness in treating peanut
allergies, revolutionizes the management of food allergies by
providing long-term remission, allowing patients and families to
live without the constant fear of allergic reactions.
About Food Allergy Institute (FAI): FAI is dedicated
to advancing the treatment and understanding of food allergies
through innovative research and patient-centered care. With over
8,000 patients achieving complete food freedom, FAI continues to
lead the way in allergy treatment and management.
Media Assets:
- See heartfelt video and images here, of kids in remission
eating ice cream for the first time.
- Interview with Dr. Randhawa or Dr. Marsteller
- Interview(s) with any of the families depicted in the media
assets
View original content to download
multimedia:https://www.prnewswire.com/news-releases/groundbreaking-study-by-food-allergy-institute-reveals-lasting-solution-for-children-with-milk-allergies-302181062.html
SOURCE Food Allergy Institute